Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discrimination of Different Brain Metastases and Primary CNS Lymphomas Using Morphologic Criteria and Diffusion Tensor Imaging.
Bette S, Wiestler B, Delbridge C, Huber T, Boeckh-Behrens T, Meyer B, Zimmer C, Gempt J, Kirschke J. Bette S, et al. Among authors: wiestler b. Rofo. 2016 Dec;188(12):1134-1143. doi: 10.1055/s-0042-115572. Epub 2016 Sep 19. Rofo. 2016. PMID: 27643802 Free article. English.
Key Points: Histopathological subtypes of brain metastases/CNS lymphomas show different morphologic features on MRI Primary CNS lymphomas show significantly reduced ADC values DTI is not a reliable tool for differentiation between brain metastases Citation Format: Bette S, Wie …
Key Points: Histopathological subtypes of brain metastases/CNS lymphomas show different morphologic features on MRI Primary CNS lymphomas sh …
Fully automated analysis combining [18F]-FET-PET and multiparametric MRI including DSC perfusion and APTw imaging: a promising tool for objective evaluation of glioma progression.
Paprottka KJ, Kleiner S, Preibisch C, Kofler F, Schmidt-Graf F, Delbridge C, Bernhardt D, Combs SE, Gempt J, Meyer B, Zimmer C, Menze BH, Yakushev I, Kirschke JS, Wiestler B. Paprottka KJ, et al. Among authors: wiestler b. Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4445-4455. doi: 10.1007/s00259-021-05427-8. Epub 2021 Jun 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 34173008 Free PMC article.
Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy.
Gempt J, Withake F, Aftahy AK, Meyer HS, Barz M, Delbridge C, Liesche-Starnecker F, Prokop G, Pfarr N, Schlegel J, Meyer B, Zimmer C, Menze BH, Wiestler B. Gempt J, et al. Among authors: wiestler b. ESMO Open. 2022 Oct;7(5):100566. doi: 10.1016/j.esmoop.2022.100566. Epub 2022 Aug 30. ESMO Open. 2022. PMID: 36055049 Free PMC article.
Benchmarking the CoW with the TopCoW Challenge: Topology-Aware Anatomical Segmentation of the Circle of Willis for CTA and MRA.
Yang K, Musio F, Ma Y, Juchler N, Paetzold JC, Al-Maskari R, Höher L, Li HB, Hamamci IE, Sekuboyina A, Shit S, Huang H, Prabhakar C, de la Rosa E, Waldmannstetter D, Kofler F, Navarro F, Menten M, Ezhov I, Rueckert D, Vos I, Ruigrok Y, Velthuis B, Kuijf H, Hämmerli J, Wurster C, Bijlenga P, Westphal L, Bisschop J, Colombo E, Baazaoui H, Makmur A, Hallinan J, Wiestler B, Kirschke JS, Wiest R, Montagnon E, Letourneau-Guillon L, Galdran A, Galati F, Falcetta D, Zuluaga MA, Lin C, Zhao H, Zhang Z, Ra S, Hwang J, Park H, Chen J, Wodzinski M, Müller H, Shi P, Liu W, Ma T, Yalçin C, Hamadache RE, Salvi J, Llado X, Lal-Trehan Estrada UM, Abramova V, Giancardo L, Oliver A, Liu J, Huang H, Cui Y, Lin Z, Liu Y, Zhu S, Patel TR, Tutino VM, Orouskhani M, Wang H, Mossa-Basha M, Zhu C, Rokuss MR, Kirchhoff Y, Disch N, Holzschuh J, Isensee F, Maier-Hein K, Sato Y, Hirsch S, Wegener S, Menze B. Yang K, et al. Among authors: wiestler b. ArXiv [Preprint]. 2024 Apr 29:arXiv:2312.17670v3. ArXiv. 2024. PMID: 38235066 Free PMC article. Preprint.
Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.
Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MLP, O'Rourke DM, Mohan S, Davatzikos C; ReSPOND consortium. Akbari H, et al. Among authors: wiestler b. Neuro Oncol. 2024 Dec 12:noae260. doi: 10.1093/neuonc/noae260. Online ahead of print. Neuro Oncol. 2024. PMID: 39665363
237 results